BioSpace News Archive

Biotech Beach

SeaSpine® Announces 50,000th NanoMetalene® Implantation

SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the implantation of the 50,000th NanoMetalene® interbody device.

March 24, 2022
·
3 min read
Business

Imago BioSciences Reports Fourth Quarter and Full Year 2021 Financial Results

Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs) and other bone marrow diseases, today reported financial results for the full year ended December 31, 2021.

March 24, 2022
·
15 min read
Biotech Bay

GBT Announces Participation at the Guggenheim Genomic Medicines & Rare Disease Day

Global Blood Therapeutics, Inc. announced that it will participate in a virtual fireside chat at the Guggenheim Genomic Medicines & Rare Disease Day on Friday, April 1, 2022, at 12:00 p.m. E.T.

March 24, 2022
·
1 min read
Business

Panbela Provides Business Update and Reports Q4 and FY 2021 Financial Results

Panbela Therapeutics, Inc., a clinical stage company developing disruptive therapeutics for the treatment of patients with cancer, provides a business update and reports financial results for the quarter and full year ended December 31, 2021.

March 24, 2022
·
14 min read
Business

Bellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational Update

Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today reported financial results for the fourth quarter and full year 2021 and provided an operational update.

March 24, 2022
·
10 min read
Biotech Beach

Sientra to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT

Sientra, Inc. announced that Company CEO Ron Menezes has been invited to present at the 2022 Virtual Growth Conference, hosted by Maxim Group LLC and hosted by M-Vest, on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT.

March 24, 2022
·
1 min read
Business

Nyxoah Reports Full Year 2021 Operating and Financial Results

Nyxoah SA, a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, reported financial and operating results for the full year ending December 31, 2021.

March 24, 2022
·
15 min read
Business

Diagnostic Industry Veteran Karin Eastham to Chair Personalis Board of Directors

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that Karin Eastham has been appointed as Personalis’ new Board Chair effective as of Personalis’ Annual Meeting of Stockholders on May 17, 2022.

March 24, 2022
·
5 min read
Policy

Aquavit Files IND with FDA for DTX-021, a New Botulinum Toxin

Aquavit Pharmaceuticals, Inc. announced that it has submitted its IND package for a new botulinum toxin to the FDA for approval.

March 24, 2022
·
2 min read
Ascendis Pharma Prices US$500.0 Million Convertible Senior Notes Offering

Ascendis Pharma A/S announced the pricing of its offering of US$500,000,000 aggregate principal amount of 2.25% convertible senior notes due 2028 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

March 24, 2022
·
8 min read